Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN116947746A details a novel homogeneous reaction system enhancing purity and clarity stability for high-purity sodium picosulfate manufacturing.
Patent CN1049656A discloses novel lipoxygenase inhibitors. Efficient synthesis via sulfonyl isocyanate coupling offers cost-effective API intermediate manufacturing solutions.
Novel green route for Abemaciclib intermediate using Selectfluor. Eliminates Palladium residues and reduces costs. Ideal for API manufacturing scale-up.
Patent CN116947746A reveals a novel homogeneous synthesis route for sodium picosulfate, ensuring superior clarity and reduced isomer impurities for reliable supply chains.
Patent CN101307048A details a novel stereoselective method for Lamivudine using chiral auxiliaries, offering superior purity and cost-effective manufacturing for global supply chains.
Patent CN120757482A reveals manganese catalysis for high-purity indole carbazole intermediates ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel catalytic method for halogenated biphenyl intermediates. High yield, reduced cost, scalable production for pharmaceutical applications ensuring supply chain reliability.
Patent CN102432642B enables high-yield synthesis of antitumor intermediates with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN119431252A reveals Lewis acid catalyzed cycloaddition for high-purity intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel zinc-mediated debromination process for biphenyl compounds offers high yield and mother liquor recycling for cost-effective Sartan intermediate manufacturing.
Advanced solid chiral catalyst process for florfenicol intermediates. Enhances yield, reduces environmental impact, and ensures supply chain reliability for veterinary drug manufacturers.
Novel synthesis of Levetiracetam avoiding toxic reagents. High purity API intermediate manufacturing with reduced environmental impact.
Patent CN114805395B details a continuous synthesis of ACB-7 with high yield, avoiding toxic reagents. Ideal for reliable pharmaceutical intermediates supply chains.
Novel preparation method for high purity Moxifloxacin Impurity J ensuring supply chain stability and cost efficiency for pharmaceutical quality control standards.
Patent CN102010381B details a low-toxicity valsartan synthesis using TMSA and TBAF. Discover cost-effective, scalable API intermediate manufacturing solutions.
Patent CN103003257B details a one-step L-carnitine synthesis. Offers high purity, cost reduction, and supply chain reliability for pharmaceutical intermediates.
Novel unnatural amino acid synthesis improves MAPS polypeptide purity and yield via symmetric branching, offering cost-effective pharma intermediate solutions.
Patent CN115651070B details thioether-bonded H2 Relaxin synthesis. Offers simplified SPPS route, enhanced stability, and cost-effective manufacturing for pharmaceutical partners.
Patent CN106279108B reveals water-phase synthesis for Rabeprazole intermediate offering environmental benefits and scalable production for global supply chains.
Advanced asymmetric oxidation process for Levpantoprazole Sodium. High purity, cost-effective manufacturing for global supply chains.